SENSOR DISORDERS AT MULTIPLE SCLEROSIS AND MEANS OF THEIR CORRECTION BY THIOCTIC ACID

Farit А Khabirov , Radij G Esin , Тimur I Khaibullin , Аlexander А Rogozhin , Natalya N Babicheva , Ludmila A Аverjanova , Еvgeny V Granatov

Neurology Bulletin ›› 2010, Vol. XLII ›› Issue (1) : 37 -40.

PDF
Neurology Bulletin ›› 2010, Vol. XLII ›› Issue (1) : 37 -40. DOI: 10.17816/nb13578
Articles
other

SENSOR DISORDERS AT MULTIPLE SCLEROSIS AND MEANS OF THEIR CORRECTION BY THIOCTIC ACID

Author information +
History +
PDF

Abstract

Thioctic acid usage was scientifically proved for the purpose of sensor disorders' correction in patients with multiple sclerosis. There was evaluated effectiveness of therapy by thioctic acid in the multiple sclerosis patients, having different sensor disorders as seen after postregistered clinical investigations. According to the preliminary results it was shown that thioctic acid can positively influence sensor disorders.

Keywords

multiple sclerosis / sensor disorders / symptomatic therapy / thioctic acid

Cite this article

Download citation ▾
Farit А Khabirov, Radij G Esin, Тimur I Khaibullin, Аlexander А Rogozhin, Natalya N Babicheva, Ludmila A Аverjanova, Еvgeny V Granatov. SENSOR DISORDERS AT MULTIPLE SCLEROSIS AND MEANS OF THEIR CORRECTION BY THIOCTIC ACID. Neurology Bulletin, 2010, XLII(1): 37-40 DOI:10.17816/nb13578

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

1. Котов, С.В. Тиоктацид в лечении больных РС в период обострений / С.В. Котов, И.Г. Рудакова, В.Ю. Лиждвой // Лечение нервных болезней. - 2003. - Т.4, № 2 (10). - С. 17-19.

[2]

2. Марков, Д.А. Рассеянный склероз / Д.А. Марков, А.Л. Леонидович. - Медицина, 1976. - 296 c.

[3]

3. Рассеянный склероз: избранные вопросы теории и практики [под ред. И.А. Завалишина, В.И. Головкина]. - М., 2000. - 640 c.

[4]

4. Хабиров, Ф.А. Рассеянный склероз. Современные аспекты диагностики и лечения: учеб. пособие для врачей / Ф.А. Хабиров, Р.Г. Есин, О.С. Кочергина и др. - Казань, 2007. - 48 c.

[5]

5. Calabrese, V. NO synthase and neurodegenerative disorders: the role of oxidant/antioxidant balance / V. Calabrese, T.E. Bates, A.M. Stella // Neurochem. Res. - 2000. - Vol. 25 (9-10). - P. 1315-1341.

[6]

6. Cosi, C. Poly (ADP-ribose) polymerase: early involvement in glutamate - induced neurotoxicity in cultured cerebellar granule cells / C. Cosi, H. Suzuki, D. Milani et al. // Neurosci. Res. - 1994. - Vol. 39 (1). - P. 38-46.

[7]

7. Salinthone, S. Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS / S. Salinthone, V. Yadav, D.N. Bourdette et al. // Endocrine, Metabolic and Immune Disorders. Drug Targets. - 2008. - Vol. 8. - P. 132-142.

[8]

8. Kararizou, E. Stereoanesthesia or astereognosia? / E. Kararizou, D. Lykomanos, A. Kosma et al. // Neurol. Sci. - 2009. - Vol. 30 (5). - P. 409-411.

[9]

9. Lincoln, N.B. Reliability and Revision of the Nottingham Sensory Assessment for Stroke Patients / N.B. Lincoln, J.M. Jackson, S.A. Adams // Physiotherapy. - 1998. - Vol. 84. - P. 358-365.

[10]

10. Numasawa, Y. Pseudoradicular sensory loss caused by a cerebral demyelinative lesion / Y. Numasawa, T. Irioka, H. Mizusawa // Intern. Med. - 2008. - Vol. 47 (13). - P. 1287-1288.

[11]

11. Osterberg, A. Central pain in multiple sclerosis - sensory abnormalities / A. Osterberg, J. Boivie // Eur. J. Pain. - 2010. - Vol. 14 (1). - P. 104-110.

[12]

12. Rae-Grant, A.D. Sensory symptoms of multiple sclerosis: a hidden reservoir of morbidity / A.D. Rae-Grant, N.J. Eckert, S. Bartz, J.F. Reed // Mult. Scler. - 1999. - Vol. 5 (3). - P. 179-183.

[13]

13. Yoshida, T. Effect of methylprednisolone-pulse therapy on superoxide production of neutrophils / T. Yoshida, M. Tanaka, A. Sotomatsu, K. Okamoto // Neurol. Res. - 1999. - Vol. 21 (5). - P. 509-512.

RIGHTS & PERMISSIONS

Khabirov F.А., Esin R.G., Khaibullin Т.I., Rogozhin А.А., Babicheva N.N., Аverjanova L.A., Granatov Е.V.

AI Summary AI Mindmap
PDF

120

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/